Cargando…
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
A broad proteomic analysis was conducted to identify and evaluate candidate biomarkers potentially predictive of response to treatment with an oral selective Janus kinase 1 (JAK1) inhibitor, itacitinib, in acute graft‐versus‐host disease (GVHD). Plasma samples from 25 participants (identification co...
Autores principales: | Pratta, Michael, Paczesny, Sophie, Socie, Gerard, Barkey, Natalie, Liu, Hao, Owens, Sherry, Arbushites, Michael C., Schroeder, Mark A., Howell, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540806/ https://www.ncbi.nlm.nih.gov/pubmed/35689489 http://dx.doi.org/10.1111/bjh.18300 |
Ejemplares similares
-
Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022) -
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
por: Socié, Gerard, et al.
Publicado: (2023) -
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022) -
The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022) -
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib
por: Srinivas, Nithya, et al.
Publicado: (2020)